Omnicomm Systems Inc (OMCM) 0.1700 $OMCM
Formedix and OmniComm Systems(R) Partnership Strengthened with the Release of Enhanced TrialMaster(R) Integration for EDC Build
PRWeb - Wed Jul 23, 11:04AM CDT
Last year, Formedix celebrated its partnership with OmniComm Systems, a leading global provider of data management solutions for clinical trials. The company launched its integration with TrialMaster, a leading-edge system for electronic data capture (EDC) and clinical data management. Formedix, a renowned provider of universal design and study execution tools added TrialMaster to its Transform for EDC product line. This latest, and much anticipated version of Transform for TrialMaster, is being released this week, in response to market demands for even tighter integration between these two prominent software products.
TFS, Top Sweden-Based Contract Research Organization, Selects OmniComm(R) TrialMaster(R) for Global Clinical Trial Research
Marketwire - Mon Jul 21, 8:18AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to announce that TFS International (TFS), the largest independent, global clinical contract research organization headquartered in Sweden, has selected TrialMaster electronic data capture (EDC) technology as its standard EDC solution for pivotal clinical trials. This whole process has been part of a company-wide initiative to provide TFS's clients around the globe with increased performance, functionality and better business decision making tools.
Leading Biotechnology Company Selects OmniComm Systems'
R) TrialMaster(R)
Marketwire - Mon Jul 07, 10:32AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of data management solutions for clinical trials, today announced that a leading biotechnology company, selected OmniComm's TrialMaster electronic data capture technology (EDC) to support three Phase III late stage clinical development studies. TrialMaster will be used for an open-labeled, multicenter, safety study and two randomized, double-blind, placebo-controlled efficacy and safety studies. OmniComm's proven technology and processes for integrating TrialMaster with other best-of-breed solutions was an important factor in selecting TrialMaster as their preferred EDC system. This leading biotechnology company will integrate TrialMaster with its preferred Interactive Response Technologies (IRT) solution. IRT solutions automate randomization and clinical supplies management and when integrated with TrialMaster EDC provides a comprehensive end-to-end solution.
OmniComm Systems(R) Signs Multi-Year Agreement With Top 5 Global CRO for TrialOne(R)
Marketwire - Wed Jun 25, 7:05AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of clinical data management solutions for clinical trials, today announced that one of the world's largest contract research organizations selected TrialOne to standardize processes, improve business intelligence, ensure regulatory compliance, and achieve overall business transformation across all of its global Phase I clinics.
Multi-Billion Dollar Global Contract Research Organization Selects OmniComm Systems' R) TrialMaster(R)
Marketwire - Wed May 28, 7:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of clinical data management solutions for clinical trials, today announced that one of the world's largest contract research organizations (CRO) with annual revenues exceeding $2 billion, selected TrialMaster electronic data capture technology (EDC) to meet its current and future data management requirements for their expanding number of Phase I and Phase IIa clinical studies. These studies are the important first step in determining the safety and tolerability of new drugs. They test how drugs are absorbed into the body, and the amount of time a drug stays in the body. The drug's safety and side effects are also evaluated at varying dose levels during these studies.
OmniComm(R) Systems Announces Major Milestone Achievement of Over 4,000 Clinical Trials
Marketwire - Tue Mar 25, 6:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for clinical trials, today announced its electronic data capture (EDC) solutions have been used in more than 4,000 live or completed clinical trials in over 55 countries across more than 30 therapeutic areas. The company's EDC solutions are widely accepted and utilized by pharmaceutical; biotechnology; contract research organizations; academic research centers and medical device companies of all sizes in all clinical trial phases. OmniComm's EDC technologies are embraced by the industry by significantly streamlining clinical processes through innovation, automation and interoperability.
Centre for Human Drug Research Selects OmniComm(R) Promasys(R) Mobile Technology
Marketwire - Wed Mar 19, 6:00AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a five year agreement with Centre for Human Drug Research (CHDR), a clinical research center in The Netherlands, for Promasys mobile electronic data capture (EDC) technology. This agreement gives CHDR the ability to capture data right at the point-of-clinical testing utilizing the latest in mobile technology.
OmniComm(R) Systems Signs $2.5 Million Deal With Major Biotechnology Company
Marketwire - Mon Mar 17, 1:41PM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a $2.5 million contract for one Phase II and four Phase III global studies with a major east coast biotechnology company to supply OmniComm's market leading electronic data capture (EDC) technology, TrialMaster 4.2. TrialMaster EDC was selected in part for its award-winning Custom Data Export Utility. This enables compliance with FDA's, soon to be mandated, requirement for all clinical data submissions to conform to the Study Data Tabulation Model (SDTM). Conventional methodologies, used for clinical data submission, are very costly and typically take months to complete. TrialMaster's Custom Data Export Utility significantly decreases time to submission and can have SDTM data sets ready within 48 hours of database lock. TrialMaster's unique capability converts clinical study data to SDTM formats during trial conduct in real time, resulting in lower costs, decreased cycle times, and reduced rework.
OmniComm Systems, Inc. Announces Major New Release of TrialMaster(R) EDC
GlobeNewswire - Mon Dec 30, 11:28AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced the production availability of Version 4.2 of TrialMaster, its flagship product for Electronic Data Capture (EDC). This new release includes hundreds of innovative productivity and functionality enhancements, including additional features for auto-redaction for faster and more efficient centralized and risked-based monitoring, and major new features for exporting data utilizing OmniComm's award winning Export Utility.
OmniComm Systems Ranks Number 481 on Deloitte's 2013 Technology Fast 500(TM) for Fastest Growing Companies in North America
GlobeNewswire - Thu Dec 26, 10:55AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced that it was ranked number 481 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America over the past 5 years. OmniComm Systems' revenue grew 148 percent over this period.
Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
PRWeb - Wed Sep 04, 9:03AM CDT
Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today it has formed a strategic partnership with OmniComm Systems, Inc., a leading provider of EDC solutions.
Top 5 Pharma Company Chooses OmniComm System's TrialMaster(R) EDC Solution for Late Phase Research
GlobeNewswire - Wed Aug 14, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialMaster(R) EDC solution has been selected by a top 5 pharmaceutical company to run a 5 year late-phase, non-interventional oncology trial.
Inflamax Research commits to use OmniComm eClinical Suite
M2 - Wed Jul 10, 10:09AM CDT
OmniComm Systems, Inc. (OTC: OMCM) said that Inflamax Research has made a five-year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.
Inflamax Research Selects OmniComm Systems' eClinical Suite to Enhance Clinical Operations
GlobeNewswire - Tue Jul 09, 8:03AM CDT
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that Inflamax Research, a full service Contract Research Organization (CRO), has made a 5 year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.
OmniComm Systems, Inc. Appoints Kuno van der Post, Ph.D. as Senior Vice President of Business Development
GlobeNewswire - Mon Jun 24, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Kuno van der Post, Ph.D. has been promoted to Senior Vice President of Business Development.
OmniComm Systems, Inc. and Soltex Consulting, LLP Announce a Strategic Partnership
GlobeNewswire - Mon Jun 17, 8:05AM CDT
OmniComm Systems, Inc. (OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, and Soltex Consulting, LLP, a leading eClinical lifecycle consulting firm, announced their new strategic partnership today. The partnership will allow OmniComm to offer best-in-class process reengineering and change management consulting to its EDC software customers, and augment OmniComm's own study build services, while allowing Soltex to offer its clients access to one of the most intuitive, productive EDC suites available on the market today.
E-Clinical Trial Technologies: Oracle Dominates - Global Strategic Business Report 2013-2018
M2 - Fri Jun 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dsxrd3/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Product Segments: Electronic Data Capture (EDC) Solutions, Clinical Trial Management System (CTMS), mElectronic Patient Reported Outcome (ePRO), Randomization and Trial Supply Management (RTSM), and Interactive Response Technology (IRT). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 112 companies including many key and niche players such as: - Almac Group - ArisGlobal LLC - BioClinica - Clinipace Worldwide - Cmed Technology Ltd. - DATATRAK International, Inc. - DSG Inc. - DZS Software Solutions, Inc. - eClinForce, Inc. - e
Top 5 Pharma Company Signs 5-Year Multi-Million Dollar Agreement for OmniComm System's TrialOne Application Suite
GlobeNewswire - Mon Jun 03, 12:41PM CDT
OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialOne(R) suite of applications has been chosen by a top 5 pharmaceutical company to automate their global clinical trial operations and processes in all their early-phase clinics.
Formedix and OmniComm Partner to Offer CRO and Sponsors Multi-Vendor EDC Capabilities
PRWeb - Tue Apr 30, 12:25PM CDT
Formedix, a leading provider of universal design and execution tools, has added to its rapidly growing Transform for Electronic Data Capture (EDC) product line. The partnership with OmniComm Systems, a full-service, global eClinical and EDC software and services company, provides integration with TrialMaster, a leading-edge system for Electronic Data Capture and Clinical Data Management.
Intersect ENT Selects OmniComm Systems' TrialMaster(R) EDC Solution
GlobeNewswire - Mon Apr 22, 7:30AM CDT
OmniComm Systems, Inc. (OTCBB:OMCM), a leading global provider of eClinical solutions, announced today that it was selected as the EDC System of choice by Menlo Park, CA based Intersect ENT for its RESOLVE Clinical Study, a Novel In-Office Treatment option for Chronic Sinusitis Patients.
Formedix and OmniComm Systems(R) Partnership Strengthened with the Release of Enhanced TrialMaster(R) Integration for EDC Build
PRWeb - Wed Jul 23, 11:04AM CDT
Last year, Formedix celebrated its partnership with OmniComm Systems, a leading global provider of data management solutions for clinical trials. The company launched its integration with TrialMaster, a leading-edge system for electronic data capture (EDC) and clinical data management. Formedix, a renowned provider of universal design and study execution tools added TrialMaster to its Transform for EDC product line. This latest, and much anticipated version of Transform for TrialMaster, is being released this week, in response to market demands for even tighter integration between these two prominent software products.
TFS, Top Sweden-Based Contract Research Organization, Selects OmniComm(R) TrialMaster(R) for Global Clinical Trial Research
Marketwire - Mon Jul 21, 8:18AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to announce that TFS International (TFS), the largest independent, global clinical contract research organization headquartered in Sweden, has selected TrialMaster electronic data capture (EDC) technology as its standard EDC solution for pivotal clinical trials. This whole process has been part of a company-wide initiative to provide TFS's clients around the globe with increased performance, functionality and better business decision making tools.
Leading Biotechnology Company Selects OmniComm Systems'
R) TrialMaster(R) Marketwire - Mon Jul 07, 10:32AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of data management solutions for clinical trials, today announced that a leading biotechnology company, selected OmniComm's TrialMaster electronic data capture technology (EDC) to support three Phase III late stage clinical development studies. TrialMaster will be used for an open-labeled, multicenter, safety study and two randomized, double-blind, placebo-controlled efficacy and safety studies. OmniComm's proven technology and processes for integrating TrialMaster with other best-of-breed solutions was an important factor in selecting TrialMaster as their preferred EDC system. This leading biotechnology company will integrate TrialMaster with its preferred Interactive Response Technologies (IRT) solution. IRT solutions automate randomization and clinical supplies management and when integrated with TrialMaster EDC provides a comprehensive end-to-end solution.
OmniComm Systems(R) Signs Multi-Year Agreement With Top 5 Global CRO for TrialOne(R)
Marketwire - Wed Jun 25, 7:05AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of clinical data management solutions for clinical trials, today announced that one of the world's largest contract research organizations selected TrialOne to standardize processes, improve business intelligence, ensure regulatory compliance, and achieve overall business transformation across all of its global Phase I clinics.
Multi-Billion Dollar Global Contract Research Organization Selects OmniComm Systems'
R) TrialMaster(R) Marketwire - Wed May 28, 7:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of clinical data management solutions for clinical trials, today announced that one of the world's largest contract research organizations (CRO) with annual revenues exceeding $2 billion, selected TrialMaster electronic data capture technology (EDC) to meet its current and future data management requirements for their expanding number of Phase I and Phase IIa clinical studies. These studies are the important first step in determining the safety and tolerability of new drugs. They test how drugs are absorbed into the body, and the amount of time a drug stays in the body. The drug's safety and side effects are also evaluated at varying dose levels during these studies.
OmniComm(R) Systems Announces Major Milestone Achievement of Over 4,000 Clinical Trials
Marketwire - Tue Mar 25, 6:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for clinical trials, today announced its electronic data capture (EDC) solutions have been used in more than 4,000 live or completed clinical trials in over 55 countries across more than 30 therapeutic areas. The company's EDC solutions are widely accepted and utilized by pharmaceutical; biotechnology; contract research organizations; academic research centers and medical device companies of all sizes in all clinical trial phases. OmniComm's EDC technologies are embraced by the industry by significantly streamlining clinical processes through innovation, automation and interoperability.
Centre for Human Drug Research Selects OmniComm(R) Promasys(R) Mobile Technology
Marketwire - Wed Mar 19, 6:00AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a five year agreement with Centre for Human Drug Research (CHDR), a clinical research center in The Netherlands, for Promasys mobile electronic data capture (EDC) technology. This agreement gives CHDR the ability to capture data right at the point-of-clinical testing utilizing the latest in mobile technology.
OmniComm(R) Systems Signs $2.5 Million Deal With Major Biotechnology Company
Marketwire - Mon Mar 17, 1:41PM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a $2.5 million contract for one Phase II and four Phase III global studies with a major east coast biotechnology company to supply OmniComm's market leading electronic data capture (EDC) technology, TrialMaster 4.2. TrialMaster EDC was selected in part for its award-winning Custom Data Export Utility. This enables compliance with FDA's, soon to be mandated, requirement for all clinical data submissions to conform to the Study Data Tabulation Model (SDTM). Conventional methodologies, used for clinical data submission, are very costly and typically take months to complete. TrialMaster's Custom Data Export Utility significantly decreases time to submission and can have SDTM data sets ready within 48 hours of database lock. TrialMaster's unique capability converts clinical study data to SDTM formats during trial conduct in real time, resulting in lower costs, decreased cycle times, and reduced rework.
OmniComm Systems, Inc. Announces Major New Release of TrialMaster(R) EDC
GlobeNewswire - Mon Dec 30, 11:28AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced the production availability of Version 4.2 of TrialMaster, its flagship product for Electronic Data Capture (EDC). This new release includes hundreds of innovative productivity and functionality enhancements, including additional features for auto-redaction for faster and more efficient centralized and risked-based monitoring, and major new features for exporting data utilizing OmniComm's award winning Export Utility.
OmniComm Systems Ranks Number 481 on Deloitte's 2013 Technology Fast 500(TM) for Fastest Growing Companies in North America
GlobeNewswire - Thu Dec 26, 10:55AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced that it was ranked number 481 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America over the past 5 years. OmniComm Systems' revenue grew 148 percent over this period.
Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
PRWeb - Wed Sep 04, 9:03AM CDT
Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today it has formed a strategic partnership with OmniComm Systems, Inc., a leading provider of EDC solutions.
Top 5 Pharma Company Chooses OmniComm System's TrialMaster(R) EDC Solution for Late Phase Research
GlobeNewswire - Wed Aug 14, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialMaster(R) EDC solution has been selected by a top 5 pharmaceutical company to run a 5 year late-phase, non-interventional oncology trial.
Inflamax Research commits to use OmniComm eClinical Suite
M2 - Wed Jul 10, 10:09AM CDT
OmniComm Systems, Inc. (OTC: OMCM) said that Inflamax Research has made a five-year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.
Inflamax Research Selects OmniComm Systems' eClinical Suite to Enhance Clinical Operations
GlobeNewswire - Tue Jul 09, 8:03AM CDT
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that Inflamax Research, a full service Contract Research Organization (CRO), has made a 5 year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.
OmniComm Systems, Inc. Appoints Kuno van der Post, Ph.D. as Senior Vice President of Business Development
GlobeNewswire - Mon Jun 24, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Kuno van der Post, Ph.D. has been promoted to Senior Vice President of Business Development.
OmniComm Systems, Inc. and Soltex Consulting, LLP Announce a Strategic Partnership
GlobeNewswire - Mon Jun 17, 8:05AM CDT
OmniComm Systems, Inc. (OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, and Soltex Consulting, LLP, a leading eClinical lifecycle consulting firm, announced their new strategic partnership today. The partnership will allow OmniComm to offer best-in-class process reengineering and change management consulting to its EDC software customers, and augment OmniComm's own study build services, while allowing Soltex to offer its clients access to one of the most intuitive, productive EDC suites available on the market today.
E-Clinical Trial Technologies: Oracle Dominates - Global Strategic Business Report 2013-2018
M2 - Fri Jun 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dsxrd3/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Product Segments: Electronic Data Capture (EDC) Solutions, Clinical Trial Management System (CTMS), mElectronic Patient Reported Outcome (ePRO), Randomization and Trial Supply Management (RTSM), and Interactive Response Technology (IRT). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 112 companies including many key and niche players such as: - Almac Group - ArisGlobal LLC - BioClinica - Clinipace Worldwide - Cmed Technology Ltd. - DATATRAK International, Inc. - DSG Inc. - DZS Software Solutions, Inc. - eClinForce, Inc. - e
Top 5 Pharma Company Signs 5-Year Multi-Million Dollar Agreement for OmniComm System's TrialOne Application Suite
GlobeNewswire - Mon Jun 03, 12:41PM CDT
OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialOne(R) suite of applications has been chosen by a top 5 pharmaceutical company to automate their global clinical trial operations and processes in all their early-phase clinics.
Formedix and OmniComm Partner to Offer CRO and Sponsors Multi-Vendor EDC Capabilities
PRWeb - Tue Apr 30, 12:25PM CDT
Formedix, a leading provider of universal design and execution tools, has added to its rapidly growing Transform for Electronic Data Capture (EDC) product line. The partnership with OmniComm Systems, a full-service, global eClinical and EDC software and services company, provides integration with TrialMaster, a leading-edge system for Electronic Data Capture and Clinical Data Management.
Intersect ENT Selects OmniComm Systems' TrialMaster(R) EDC Solution
GlobeNewswire - Mon Apr 22, 7:30AM CDT
OmniComm Systems, Inc. (OTCBB:OMCM), a leading global provider of eClinical solutions, announced today that it was selected as the EDC System of choice by Menlo Park, CA based Intersect ENT for its RESOLVE Clinical Study, a Novel In-Office Treatment option for Chronic Sinusitis Patients.
